Henry Schein, Inc. (HSIC) Position Cut by Teachers Advisors LLC
Teachers Advisors LLC lessened its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 29.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 102,985 shares of the company’s stock after selling 42,787 shares during the quarter. Teachers Advisors LLC owned about 0.13% of Henry Schein worth $18,848,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also modified their holdings of the stock. Eads & Heald Investment Counsel raised its stake in Henry Schein by 0.5% during the 2nd quarter. Eads & Heald Investment Counsel now owns 1,497 shares of the company’s stock valued at $274,000 after purchasing an additional 8 shares during the period. Cleararc Capital Inc. raised its stake in Henry Schein by 0.6% during the 1st quarter. Cleararc Capital Inc. now owns 1,950 shares of the company’s stock valued at $331,000 after purchasing an additional 11 shares during the period. Intrust Bank NA raised its stake in Henry Schein by 1.1% during the 2nd quarter. Intrust Bank NA now owns 1,219 shares of the company’s stock valued at $223,000 after purchasing an additional 13 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in Henry Schein by 0.3% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 5,894 shares of the company’s stock valued at $1,079,000 after purchasing an additional 19 shares during the period. Finally, Sawtooth Solutions LLC raised its stake in Henry Schein by 2.4% during the 2nd quarter. Sawtooth Solutions LLC now owns 1,347 shares of the company’s stock valued at $247,000 after purchasing an additional 32 shares during the period. 44.52% of the stock is currently owned by institutional investors.
Several brokerages recently issued reports on HSIC. Credit Suisse Group reissued a “hold” rating and set a $80.00 target price on shares of Henry Schein in a research note on Thursday, July 13th. Zacks Investment Research downgraded Henry Schein from a “buy” rating to a “hold” rating in a research note on Thursday, June 15th. Royal Bank Of Canada began coverage on Henry Schein in a research note on Tuesday, September 19th. They set a “sector perform” rating and a $91.00 target price on the stock. Stifel Nicolaus reissued a “hold” rating on shares of Henry Schein in a research note on Thursday, July 6th. Finally, Piper Jaffray Companies began coverage on Henry Schein in a research note on Monday, June 12th. They set a “neutral” rating and a $100.00 target price on the stock. One research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and seven have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $92.85.
In other Henry Schein news, SVP Paul Rose sold 2,126 shares of the firm’s stock in a transaction on Wednesday, September 6th. The stock was sold at an average price of $172.51, for a total transaction of $366,756.26. Following the completion of the sale, the senior vice president now owns 17,841 shares of the company’s stock, valued at $3,077,750.91. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 1.27% of the stock is owned by company insiders.
Shares of Henry Schein, Inc. (HSIC) opened at 80.34 on Tuesday. The company has a market cap of $6.35 billion, a P/E ratio of 11.74 and a beta of 1.10. Henry Schein, Inc. has a 1-year low of $73.11 and a 1-year high of $93.50. The firm has a 50-day moving average price of $85.78 and a 200-day moving average price of $88.02.
Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, August 8th. The company reported $0.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.86 by $0.02. The company had revenue of $3.06 billion during the quarter, compared to analysts’ expectations of $3.05 billion. Henry Schein had a return on equity of 19.91% and a net margin of 4.59%. The firm’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter last year, the firm earned $0.82 earnings per share. On average, equities analysts expect that Henry Schein, Inc. will post $3.64 EPS for the current year.
Henry Schein announced that its Board of Directors has authorized a share buyback plan on Monday, September 18th that permits the company to repurchase $400.00 million in shares. This repurchase authorization permits the company to purchase up to 6.3% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company’s management believes its stock is undervalued.
WARNING: This piece was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this piece on another site, it was stolen and republished in violation of international copyright & trademark laws. The legal version of this piece can be viewed at https://www.watchlistnews.com/henry-schein-inc-hsic-position-cut-by-teachers-advisors-llc/1588513.html.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.